Weihua Hou

A novel bispecific c-MET/PD-1 antibody with therapeutic potential in solid cancer

Zujun Sun, Yi Wu, Weihua Hou et al. · Oncotarget · 2017 · 40 citations · Full text

Medicine, Cancer Biology, Oncology +17

Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors

Xingxing Yuan, Zujun Sun, Qingyun Yuan et al. · Investigational New Drugs · 2020 · 31 citations

Life Sciences, Immunology, Oncology +14

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer

Weihua Hou, Qingyun Yuan, Xingxing Yuan et al. · Investigational New Drugs · 2018 · 21 citations

Medicine, Medicinal Chemistry, Oncology +17

Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy

Qingyun Yuan, Qiaoyan Liang, Zujun Sun et al. · OncoImmunology · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Bromodomain-containing protein 2 induces insulin resistance via the mTOR/Akt signaling pathway and an inflammatory response in adipose tissue

Ruixin Sun, Yi‐Long Wu, Weihua Hou et al. · Cellular Signalling · 2016 · 18 citations

Life Sciences, Endocrinology, Molecular Biology +17